Wrapping Up the Role of Pericytes in Parkinson's Disease

Overview

Journal Neural Regen Res

Date 2023 Jun 7

PMID 37282465

Authors

Taylor John Stevenson

Birger Victor Dieriks

Affiliations

Soon will be listed here.

Citing Articles

Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility.

Wiseman J, Murray H, Faull R, Dragunow M, Turner C, Dieriks B NPJ Parkinsons Dis. 2024; 10(1):1.

PMID: 38167744 PMC: 10762179. DOI: 10.1038/s41531-023-00614-w.

References

Dave J, Mirabella T, Weatherbee S, Greif D . Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain. Dev Cell. 2018; 44(6):665-678.e6. PMC: 5871595. DOI: 10.1016/j.devcel.2018.01.018. View

Altay M, Liu A, Holton J, Parkkinen L, Lashuel H . Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol Commun. 2022; 10(1):163. PMC: 9652889. DOI: 10.1186/s40478-022-01468-8. View

Reddy K, Dieriks B . Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad. Mol Neurodegener. 2022; 17(1):77. PMC: 9701437. DOI: 10.1186/s13024-022-00579-z. View

Dieriks B, Highet B, Alik A, Bellande T, Stevenson T, Low V . Human pericytes degrade diverse α-synuclein aggregates. PLoS One. 2022; 17(11):e0277658. PMC: 9674377. DOI: 10.1371/journal.pone.0277658. View

Guo J, Huang X, Dou L, Yan M, Shen T, Tang W . Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022; 7(1):391. PMC: 9755275. DOI: 10.1038/s41392-022-01251-0. View

Lendahl U, Nilsson P, Betsholtz C . Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes. EMBO Rep. 2019; 20(11):e48070. PMC: 6831996. DOI: 10.15252/embr.201948070. View

Malmberg M, Malm T, Gustafsson O, Sturchio A, Graff C, Espay A . Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology. Front Neurosci. 2020; 14:256. PMC: 7186396. DOI: 10.3389/fnins.2020.00256. View

Elabi O, Gaceb A, Carlsson R, Padel T, Soylu-Kucharz R, Cortijo I . Human α-synuclein overexpression in a mouse model of Parkinson's disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci Rep. 2021; 11(1):1120. PMC: 7806665. DOI: 10.1038/s41598-020-80889-8. View

Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M . α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Sci Rep. 2017; 7:42984. PMC: 5322400. DOI: 10.1038/srep42984. View

10.

Zhang C, Pei Y, Zhang Z, Xu L, Liu X, Jiang L . C-terminal truncation modulates α-Synuclein's cytotoxicity and aggregation by promoting the interactions with membrane and chaperone. Commun Biol. 2022; 5(1):798. PMC: 9363494. DOI: 10.1038/s42003-022-03768-0. View

11.

Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M . Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019; 565(7740):505-510. PMC: 7116578. DOI: 10.1038/s41586-018-0858-8. View

12.

Stevenson T, Johnson R, Savistchenko J, Rustenhoven J, Woolf Z, Smyth L . Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress. Sci Rep. 2022; 12(1):17314. PMC: 9569325. DOI: 10.1038/s41598-022-20261-0. View

13.

Sorrentino Z, Giasson B . The emerging role of α-synuclein truncation in aggregation and disease. J Biol Chem. 2020; 295(30):10224-10244. PMC: 7383394. DOI: 10.1074/jbc.REV120.011743. View

14.

Uemura M, Maki T, Ihara M, Lee V, Trojanowski J . Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia. Front Aging Neurosci. 2020; 12:80. PMC: 7171590. DOI: 10.3389/fnagi.2020.00080. View